GT Biopharma (GTBP) announced the appointment of Andrew Ritter to its Board of Directors. Ritter will be replacing current board member Dr. Rajesh Shrotriya, who is resigning from his position.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GTBP: